ArticleAmino acids2025
Protective effects of S-adenosyl methionine on oxidative stress and tissue damage in STZ-induced diabetic rats.
Article in Amino acids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Protective Effects of Lactobacillus-Derived Probiotics and Postbiotics on Renal and Reproductive Function in Escherichia coli-Infected Rats.Veterinary medicine and science · 2026Article
- High-Glucose-Induced Metabolic and Epithelial Stress in Grass Carp Intestinal Epithelial Cells Associated with Methylation-Related Transcriptional Responses.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOxidative stress is a key contributor to the progression of diabetes mellitus and its associated complications. Recently, S-adenosyl methionine (SAM) has shown promise in mitigating oxidative stress and improving glucose metabolism. This study aimed to investigate the effects of SAM supplementation on biochemical parameters, oxidative stress markers, and histopathological alterations in the kidneys and liver of streptozotocin (STZ)-induced diabetic rats.
methodsEighteen male Wistar rats were randomly divided into three groups (n = 6 per group): non-diabetic control, diabetic control, and diabetic rats treated with SAM (10 mg/kg/day, intraperitoneally) for 4 weeks. Fasting blood glucose, renal and hepatic biochemical markers (urea, creatinine, ALT, AST), and oxidative stress markers (malondialdehyde, protein carbonyls, total antioxidant capacity) were measured. Histopathological changes in kidney and liver tissues were also assessed.
resultsDiabetic rats treated with SAM exhibited minor, non-significant changes in fasting blood glucose, urea, creatinine, ALT, and AST levels. In contrast, treatment with SAM in diabetic rats significantly reduced malondialdehyde and protein carbonyl levels in both kidney and liver tissues compared to the diabetic control group (P < 0.05). Furthermore, histopathological analysis revealed improved tissue architecture and reduced pathological changes in the diabetic group treated with SAM.
conclusionOur findings demonstrated that SAM supplementation exerts significant antioxidant and histopathological protective effects against diabetes-induced damage in kidney and liver tissues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.